A Study of the Impact of Methotrexate (MTX) Discontinuation on the Efficacy of Subcutaneous (SC) Tocilizumab (TCZ) With MTX

NCT01855789 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

718

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Tocilizumab (TCZ)
DRUG: Methotrexate (MTX)
DRUG: Placebo (PBO)

Sponsor

Hoffmann-La Roche